ACADIA Pharmaceuticals Inc. (ACAD)
Biotechnology · Healthcare · $3.6B
Intrinsic Value (Consensus)
$29.10
Current Price
$21.09
Margin of Safety
+38%
38% Below Intrinsic Value
Value: $29
Price: $21
Valuation Model Estimates
Current Price: $21.09
DCF (Discounted Cash Flow)
$28.82
Graham Number
$19.27
Earnings Power Value
$22.33
Relative Value (P/E)
$46.00
Dividend Discount Model
Not applicable
—
Consensus Value
$29.10
Model Assumptions
Discount Rate
10.3%
Growth Rate
20.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Key Financials
- EPS (TTM)
- $2.30
- EPS (Forward)
- $2.76
- Book Value
- $7.17
- P/E Ratio
- 20.0
- Forward P/E
- 16.7
- PEG Ratio
- —
- ROE
- 31.9%
- Debt/Equity
- —
- Revenue Growth
- 11.9%
- Earnings Growth
- 20.0%
- Dividend Yield
- N/A
- Beta
- 0.83
Data last updated: 2026-06-12
Source: Yahoo Finance